Upper circuit stock: Nureca hits upper circuit after Hornbill Orchid India acquires 1.95 per cent stake

Hornbill Orchid India acquired 1.95 lakh equity shares (1.95 per cent) of Nureca at Rs 1,627.50 via a bulk deal on June 23, 2021.   

Reacting to this, Nureca‘s stock today increased by 5 per cent and made an intraday high of Rs 1,627.50 per share. The stock of the company has increased by 145 per cent from its decline in May 2020.  

The company reported a net profit of Rs 3.89 crore in Q4FY21. In Q4FY20, it had reported a net profit of Rs 2.38 crore, which is an increase of 63.35 per cent. The company reported net sales of Rs 31.84 crore for Q4FY21, a decrease of 3.4 per cent as against the net sales of Rs 32.96 crore for Q4FY20.  

Nureca is engaged in the business of home healthcare & wellness products under the brand, 'Dr Trust'. It helps its customers with tools to help them monitor chronic ailments & other diseases and also, to improve their lifestyle.   

According to BSE data, the stock traded at a price-to-book ratio of 9.97. The stock has a 52-week high and a 52-week low of Rs 1,770 and Rs 559.25, respectively.  

At the time of market closing, the share of the company was trading at Rs 1,627.50 per share on BSE, up by 5 per cent.